These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11871462)

  • 1. Pathogenesis of HIV-associated cardiovascular complications.
    Barbaro G; Fisher SD; Lipshultz SE
    Lancet Infect Dis; 2001 Sep; 1(2):115-24. PubMed ID: 11871462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of HIV-associated cardiomyopathy.
    Barbaro G; Lipshultz SE
    Ann N Y Acad Sci; 2001 Nov; 946():57-81. PubMed ID: 11762996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era.
    Cingolani A; Fratino L; Scoppettuolo G; Antinori A
    J Neurovirol; 2005; 11 Suppl 3():38-44. PubMed ID: 16540454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
    Guillén S; García San Miguel L; Resino S; Bellón JM; González I; Jiménez de Ory S; Muñoz-Fernández MA; Navarro ML; Gurbindo MD; de José MI; Mellado MJ; Martín-Fontelos P; Gonzalez-Tomé MI; Martinez J; Beceiro J; Roa MA; Ramos JT;
    HIV Med; 2010 Apr; 11(4):245-52. PubMed ID: 20050937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of organ-specific complications of human immunodeficiency virus infection in children with use of highly active antiretroviral therapy.
    Saulsbury F
    Clin Infect Dis; 2001 Feb; 32(3):464-8. PubMed ID: 11170955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric human immunodeficiency virus infection and cancer in the highly active antiretroviral treatment (HAART) era.
    Chiappini E; Berti E; Gianesin K; Petrara MR; Galli L; Giaquinto C; de Martino M; De Rossi A
    Cancer Lett; 2014 May; 347(1):38-45. PubMed ID: 24513180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital.
    Riveiro-Barciela M; Falcó V; Burgos J; Curran A; Van den Eynde E; Navarro J; Villar del Saz S; Ocaña I; Ribera E; Crespo M; Pahissa A
    HIV Med; 2013 Jan; 14(1):21-30. PubMed ID: 22726389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial disease in human immunodeficiency virus (HIV) infection: a review.
    Sani MU
    Wien Klin Wochenschr; 2008; 120(3-4):77-87. PubMed ID: 18322768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
    Barbaro G; Barbarini G
    Chemotherapy; 2006; 52(4):161-5. PubMed ID: 16675900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis predisposition in children with human immunodeficiency virus.
    Hatherill M
    Pediatr Crit Care Med; 2005 May; 6(3 Suppl):S92-8. PubMed ID: 15857567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous and arterial thromboembolic complications associated with HIV infection and highly active antiretroviral therapy.
    Auerbach E; Aboulafia DM
    Semin Thromb Hemost; 2012 Nov; 38(8):830-8. PubMed ID: 23041980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.